Ilyang Pharmaceutical Co Ltd banner
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 050 KRW Market Closed
Market Cap: ₩254.9B

Wall Street
Price Targets

Price Targets Summary
Ilyang Pharmaceutical Co Ltd

There are no price targets for Ilyang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ilyang Pharmaceutical Co Ltd Competitors:
Price Targets
KRUS
Kura Sushi USA Inc
14% Upside
PAYX
Paychex Inc
26% Upside

Revenue
Forecast

0% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
0% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 7 years is 1%.

Operating Income
Forecast

-16% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
-16% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's operating income is -16%. The projected CAGR for the next 7 years is 23%.

Net Income
Forecast

1% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
1% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's net income is 1%. The projected CAGR for the next 7 years is 3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ilyang Pharmaceutical Co Ltd's stock price target?
Not Available

Ilyang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Ilyang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 7 years is 1%.

What is Ilyang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's operating income is -16%. The projected CAGR for the next 7 years is 23%.

What is Ilyang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
3%

For the last 9 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's net income is 1%. The projected CAGR for the next 7 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett